Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

main

practices-ip-centerforce-business-development-summit

CenterForce's Business Development Summit: Diverse Partners & Associates

CenterForce's Business Development Summit: Diverse Partners & Associates

Summary

Speakers

Natasha E. Daughtrey

Related Content

In re Cellect: Federal Circuit Opens New Path for Double Patenting Challenges

Biden Executive Order Puts Focus on Domestic Manufacturing of Inventions Created Using Federal Funding

Sens. Tillis and Coons Propose New Legislation Regarding Patentability Under § 101

MetaBirkins Post-Trial Ruling Clarifies Line Between Trademark Infringement and Free Expression and Grants Broad Injunctive Relief

Supreme Court Limits Expression-Based Defenses to Trademark Claims

Top IP, FDA, and Compliance Issues for Medtech Companies Transitioning to Data-Enabled Product Solutions

Supreme Court Affirms Amgen Patents’ Invalidity in Closely Watched Enablement Case

Supreme Court Clarifies Copyright Fair Use Defense in Andy Warhol Foundation v. Goldsmith

CenterForce's IP Strategy Summit 2023

CenterForce's Diversity in IP & Tech Summit 2023

Patent Dance Disclosures and Beyond: Recent Biosimilars Litigation at the District Court

Celebrities & the Law — The Legal Issues of the Rich & Famous

BASF's Intellectual Property Symposium

Orionis Biosciences Announces Collaboration with Genentech to Discover and Develop Molecular Glue Class Medicines

Legal Challenges to the Inflation Reduction Act: An Update on Pending Challenges and Reactions to Oral Argument in Dayton Area Chamber Of Commerce et al. v. Becerra et al.

ACI's FDA Boot Camp

Intellectual Property

Patent Litigation